Distinguished in Cervical Cancer

Hanmei Q. Lou

1 Banshan East Road, 
Hangzhou, CN 
Distinguished in Cervical Cancer
1 Banshan East Road, 
Hangzhou, CN 
OverviewLocationsClinical Research

Overview

Hanmei Lou practices in Hangzhou, China. Lou is rated as a Distinguished expert by MediFind in the treatment of Cervical Cancer. Their top areas of expertise are Cervical Cancer, Human Papillomavirus Infection, Endometrial Cancer, Lung Metastases, and Hysterectomy.

Their clinical research consists of co-authoring 29 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 22 articles and participated in 1 clinical trial in the study of Cervical Cancer.

Locations

1 Banshan East Road, Hangzhou, 310022, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Open-label, Multicenter Phase II Study of TQB2450 Injection or Combined With Anlotinib Hydrochloride Capsule in Subjects With Advanced Endometrial Cancer
A Open-label, Multicenter Phase II Study of TQB2450 Injection or Combined With Anlotinib Hydrochloride Capsule in Subjects With Advanced Endometrial Cancer
Enrollment Status: Completed
Publish Date: May 28, 2025
Intervention Type: Drug
Study Drugs: TQB2450, Anlotinib
Study Phase: Phase 2
A Multicenter, Open-label, Phase II Study of AK104（an Anti-PD-1 and Anti-CTLA-4 Bispecific Antibody) in the Treatment of Recurrent or Metastatic Cervical Cancer
A Multicenter, Open-label, Phase II Study of AK104（an Anti-PD-1 and Anti-CTLA-4 Bispecific Antibody) in the Treatment of Recurrent or Metastatic Cervical Cancer
Enrollment Status: Completed
Publish Date: March 04, 2025
Intervention Type: Drug, Biological
Study Drugs: AK104, Bevacizumab, Paclitaxel, Cisplatin, Carboplatin
Study Phase: Phase 2
View 1 Less Clinical Trial

29 Total Publications

Integrated Proteomics and Metabolomics Profiling Unveils Biomarkers and Immune Characteristics for Pelvic Lymph Node Metastasis in Cervical Cancer.
Integrated Proteomics and Metabolomics Profiling Unveils Biomarkers and Immune Characteristics for Pelvic Lymph Node Metastasis in Cervical Cancer.
Journal: Journal of proteome research
Published: October 30, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Lou's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile